Kourtney Kardashian Barker’s supplement brand, Lemme, has become the center of significant controversy, particularly with the launch of its new “Ozempic-style” weight-loss supplement, GLP-1 Daily. The Kar-Jenner sisters have long faced claims of using Ozempic for weight loss, and Kourtney's brand is now accused of capitalizing on this trend. Launched two years ago, Lemme has faced criticism for several products, with experts and fans questioning their scientific validity and ethical marketing practices.

The latest product, GLP-1 Daily, directly references the GLP-1 hormone, which Ozempic , a drug originally for diabetes but popular for weight loss — mimics. Ozempic contains a synthetic version of this hormone, slowing digestion, reducing hunger, and aiding in weight loss.Lemme's GLP-1 Daily, however, does not contain the key synthetic ingredients found in Ozempic. Instead, it aims to naturally increase GLP-1 levels using lemon and saffron extracts. Despite not explicitly comparing her product to Ozempic, Kourtney promoted an article discussing her desire to be “in on the Ozempic boom,” and the brand marketed it as “a GLP-1 solution without the side effects” of the injectable drug.

Photo Credit: Daily Mail

This marketing strategy immediately drew backlash from fans and medical professionals alike. Critics quickly pointed out the alleged “facade and false marketing,” arguing that oral supplements cannot effectively mimic GLP-1 medications for weight loss due to enzymatic breakdown. Plastic surgeonNaveen Cavale slammed Kourtney for “cashing in” on young women struggling with body image, calling the product “incredibly misleading.”

He emphasized that the supplement lacks the scientifically proven impact of injectable medications like Ozempic, which contains semaglutide, a rigorously tested GLP-1 receptor. Cavale warned that such products offer “false hope” and could lead to “frustration, feelings of failure and worsened body image issues,” intensifying anxiety and depression. Priced at an “eye-watering £69 for 30 servings,” with a monthly subscription at £55.23, the GLP-1 Daily is seen by many as an exploitation of insecurities.

Health experts reiterate that Ozempic works by regulating blood sugar, reducing appetite, and slowing digestion, leading to effective weight management, which Lemme's plant-based extracts are not clinically proven to achieve for significant weight loss. Furthermore, the small print for Lemme's products consistently reveals that its claims have not been evaluated by the Food and Drug Administration (FDA),stating, “This product is not intended to diagnose, treat, cure or prevent any disease.” The FDA ensures the safety and efficacy of drugs and approved supplements, a standard Lemme's products do not meet.

Photo Credit: WWD

The GLP-1 Daily is not the first Lemme product to face scrutiny. Kourtney, known as the most health-conscious Kardashian sister, launched Lemme in September 2022 with a mission to create “science-backed” vitamins. However, her brand's offerings have repeatedly stirred controversy. Lemme Smooth, a daily tablet claiming to reduce cellulite in just 28 days, was also met with skepticism. Naveen Cavale called it “a fad” and an “ineffective solution to a perfectly normal condition,” noting that anti-cellulite pills lack scientific backing. He urged consumers to adopt a holistic approach to health rather than relying on “dubious products.”

Another product, Lemme Purr,marketed as vagina gummies to boost vaginal health and alter its taste, drew sharp criticism from gynecologistDr. Jen Gunter. Dr. Gunter publicly stated, “Anyone who suggests that your vagina isn't fresh or needs an improved taste is a misogynist and awful person. And yes, that includes you Kourtney Kardashian and your Lemme grift,” also disputing claims about pineapple affecting bodily fluid taste. These instances highlight a recurring theme: Lemme's products often make bold claims lacking robust scientific evidence, leading to accusations of exploiting societal pressures and insecurities for profit.